These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
405 related items for PubMed ID: 19097827
1. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients. Laine L, Perry JD, Lee J, Oliver M, James AL, De La Foata C, Halimi D, Orenga S, Galloway A, Gould FK. J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827 [Abstract] [Full Text] [Related]
2. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media. Perry JD, Laine L, Hughes S, Nicholson A, Galloway A, Gould FK. J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821 [Abstract] [Full Text] [Related]
5. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. da Silva Filho LV, Tateno AF, Martins KM, Azzuz Chernishev AC, Garcia Dde O, Haug M, Meisner C, Rodrigues JC, Döring G. Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007 [Abstract] [Full Text] [Related]
6. Evaluation of the efficacy of real-time polymerase chain reaction for the routine early detection of Pseudomonas aeruginosa in cystic fibrosis sputum and throat swab specimens. Logan C, Habington A, Lennon G, Cronin F, O'Sullivan N. Diagn Microbiol Infect Dis; 2010 Dec; 68(4):358-65. PubMed ID: 20884156 [Abstract] [Full Text] [Related]
7. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. Foweraker JE, Laughton CR, Brown DF, Bilton D. J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175 [Abstract] [Full Text] [Related]
8. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR. da Silva Filho LV, Tateno AF, Velloso Lde F, Levi JE, Fernandes S, Bento CN, Rodrigues JC, Ramos SR. Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555 [Abstract] [Full Text] [Related]
9. Quantitative effect of roxithromycin and rifampicin on mucoid cultures from directly plated sputum of cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa. Dupont MJ, Lapointe JR. Drugs Exp Clin Res; 1990 Jun; 16(12):597-605. PubMed ID: 2130001 [Abstract] [Full Text] [Related]
10. [Evaluation of a new E-test method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis]. Zebouh M, Thomas C, Honderlick P, Lemee L, Segonds C, Wallet F, Husson MO. Pathol Biol (Paris); 2005 Jun; 53(8-9):490-4. PubMed ID: 16087300 [Abstract] [Full Text] [Related]
11. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Hogardt M, Schmoldt S, Götzfried M, Adler K, Heesemann J. J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615 [Abstract] [Full Text] [Related]
12. Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis. Baltimore RS, Radnay-Baltimore K, von Graevenitz A, Dolan TF. Helv Paediatr Acta; 1982 Dec; 37(6):547-54. PubMed ID: 6820015 [Abstract] [Full Text] [Related]
13. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Bradbury R, Champion A, Reid DW. Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887 [Abstract] [Full Text] [Related]
14. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Vogelberg C, Hirsch T, Rösen-Wolff A, Kerkmann ML, Leupold W. Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050 [Abstract] [Full Text] [Related]
15. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis. Zebouh M, Thomas C, Honderlick P, Lemee L, Segonds C, Wallet F, Husson MO. J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727 [Abstract] [Full Text] [Related]
16. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Hansen CR, Pressler T, Høiby N. J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078 [Abstract] [Full Text] [Related]
17. Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. Wellinghausen N, Köthe J, Wirths B, Sigge A, Poppert S. J Clin Microbiol; 2005 Aug; 43(8):4070-5. PubMed ID: 16081953 [Abstract] [Full Text] [Related]
18. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum. Schiller NL, Millard RL. Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945 [Abstract] [Full Text] [Related]
19. Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance. Goncalves-Vidigal P, Grosse-Onnebrink J, Mellies U, Buer J, Rath PM, Steinmann J. J Cyst Fibros; 2011 Dec; 10(6):422-7. PubMed ID: 21763218 [Abstract] [Full Text] [Related]
20. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. Valenza G, Tappe D, Turnwald D, Frosch M, König C, Hebestreit H, Abele-Horn M. J Cyst Fibros; 2008 Mar; 7(2):123-7. PubMed ID: 17693140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]